期刊文献+

含CpG寡脱氧核苷酸对小鼠肝癌的生长抑制作用及造血功能的影响

Effect of oligodeoxynucleotide containing CpG motifs on inhibition of hepatoma-22 cell growth and hemopoiesis
下载PDF
导出
摘要 目的 观察含CpG寡脱氧核苷酸 (CpGODN)对种植小鼠肝癌 (hepatoma 2 2 ,H2 2 )的生长抑制作用及对荷瘤小鼠造血功能的影响。方法 右股皮下接种H2 2 细胞后的BALB/C小鼠 ,随机分为 7组 ,包括生理盐水组、非CpGODN组、CpGODN组、5 氟尿嘧啶 (5 FU)组、白细胞介素 2 (IL 2 )组、CpGODN +5 FU组和IL 2 +5 FU组。皮下注射给药 ,给药期间鼠尾静脉采血观察骨髓抑制情况。用药 12天 ,于最后一次用药 2 4h后颈椎脱臼处死小鼠 ,剥离肿瘤 ,测量大小和称重。结果 单用CpGODN、CpGODN +5 FU、5 FU、IL 2 +5 FU的抑瘤率为 4 2 75 %、5 6 0 2 %、6 3 98%、5 7 91% (P <0 0 1) ,后两组不良反应明显 ,有显著骨髓抑制作用。结论 CpGODN对移植小鼠肝癌生长具有抑制作用 ,并能缓解化疗引起的骨髓抑制状态。 Purpose To observe the effects of oligodeoxynucleotide containing CpG motifs on inducing hepatoma rejection and hemopoiesis. Methods H 22 cells were transplanted subcutaneously into the right back legs of BALB/C mice to establish tumor. They were divided into seven groups at random, including normal saline(control), non-CpG ODN, CpG ODN, 5-FU, IL-2, CpG+5-FU and IL-2+5-FU, which were injected subcutaneously nearby the tumor. Inhibition of bone marrow during treatment was observed by using blood of the vein of mice tail. After 24 hours of the last injection at the twelfth day, mice were killed, and the tumors were then measured and weighted. Results The rates of tumor inhibition of CpG, CpG+5-FU, 5-FU and IL-2+5-FU groups were 42.75%, 56.02%, 63.98% and 57.91% (P<0.01) respectively. The last two groups had obviously bad side reaction and bone marrow inhibition. Conclusions CpG ODN inhibits growth of the transplantated tumor of H 22 and enhances hemopoietic regeneration from myelosuppression as caused by chemical therapy.
出处 《临床与实验病理学杂志》 CAS CSCD 2004年第4期456-459,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 湖北省自然科学基金资助课题 (No 0 1JJ47 14 )
关键词 CPG寡脱氧核苷酸 小鼠 肝癌 生长抑制作用 造血功能 liver neoplasms CpG ODN 5-FU mice
  • 相关文献

参考文献13

  • 1[1]Krieg AM, Hartmann G, Yi AK, et al. Mechanism of action of CpG DNA. Curr Top Microbiol Immunol, 2000,247:1~21
  • 2[2]Agrawal S, Kandimalla ER. Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol Med, 2002,8: 114~ 21.
  • 3[3]Carpentier AF, Chen L, Maltonti F, et al. Oligodexynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. CancerRes, 1999,59:5429~32.
  • 4[4]Sparwasser T, Hultner L, Koch ES, etal. Immunostimulatory CpG-oligodeoxynucleotides cause extrameduliary murine hemopoiesis. J Immunol,1999,162:2368~74.
  • 5[5]Iho S, Yamamoto T, Takahashi T, et al. Oligodeoxynucleotides cntaining plindrome squences with iternal 5'-CpG-3'at drectly on hman NK and ativated T cells to induce IFN-γ poduction In vtro. J Immunol, 1999,163,3642~52.
  • 6[6]Roman M, Martin OE, Goodman JS, et al. Immunostimulatory DNA sequences function as TH1-promoting adjuvants. Nat Med,1997,3:849~54.
  • 7[7]Hafner M, Zawatzky R, Hirtretier C, et al. Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res,2001,61:5523~8.
  • 8[8]Yamamoto S, Yamamoto T, Iho S, et al. Activation of NK cel (human and mouse) by immunostimulatory DNA sequence.Springer Semin Immunopathol, 2000,22:35~43.
  • 9[9]Mashiba H, Matsunaga K, Tomoda H, et al. In vitro augmentation of natural killer activity of peripheral blood cells from cancer patients by a DNA fraction from mycobacterium bovis BCG. JpnJMedSciBiol, 1988,41:197~202
  • 10[10]Tokunaga T, Yamamoto H, Shimada S, et al. Antitumor activity of deoxyribonucleric acid fraction from Mycobacterium bovis BCG. 1. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst, 1984,72: 955 ~62.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部